Journal article
Tissue Plasminogen Activator and Plasminogen Activator Inhibitor Status in Budd-Chiari Syndrome
Pathophysiology of haemostasis and thrombosis, Vol.26(5), pp.284-287
1996
DOI: 10.1159/000217219
PMID: 8894659
Abstract
Alterations in the plasma levels of tissue plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI-1) as observed in various liver disorders are attributed to deranged liver function. Status of these parameters in patients with Budd-Chiari syndrome (BCS) has not been reported so far. In the present study 27 patients with BCS with hepatic and/or inferior vena cava occlusion were investigated for any defect in the fibrinolytic system. Mild to moderately deranged liver function tests were observed in all (except 2) patients. Three patients each showed mildly increased levels of t-PA (3/27) and PAI-1 (3/27). The levels of t-PA and PAI-1 however did not show any correlation with liver function parameters.
Details
- Title: Subtitle
- Tissue Plasminogen Activator and Plasminogen Activator Inhibitor Status in Budd-Chiari Syndrome
- Creators
- Sanjana DayalHara Prasad PatiMahesh Prakash Sharma
- Resource Type
- Journal article
- Publication Details
- Pathophysiology of haemostasis and thrombosis, Vol.26(5), pp.284-287
- Publisher
- Basel, Switzerland
- DOI
- 10.1159/000217219
- PMID
- 8894659
- ISSN
- 1424-8832
- eISSN
- 1424-8840
- Number of pages
- 4
- Language
- English
- Date published
- 1996
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Iowa Neuroscience Institute; Fraternal Order of Eagles Diabetes Research Center; Internal Medicine
- Record Identifier
- 9984065380902771
Metrics
21 Record Views